Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - Timber Pharmaceuticals, Inc. | a17-24000_7ex5d1.htm |
| S-1MEF - S-1MEF - Timber Pharmaceuticals, Inc. | a17-24000_7s1mef.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report (which contains an explanatory paragraph relating to the Company’s ability to continue as a going concern as described in Note 2 to the consolidated financial statements) dated April 21, 2017, relating to the consolidated financial statements of BioPharmX Corporation, which appears in the Annual Report on Form 10-K of BioPharmX Corporation for the year ended January 31, 2017.
|
/s/ BPM LLP |
|
|
|
|
|
San Jose, California |
|
|
November 20, 2017 |
|